Antiviral activity, dose–response relationship, and safety of entecavir following 24-week oral dosing in nucleoside-naive Japanese adult patients with chronic hepatitis B: a randomized, double-blind, phase II clinical trial
2009 ◽
Vol 3
(3)
◽
pp. 445-452
◽
Keyword(s):
2006 ◽
Vol 36
◽
pp. S96
◽
2006 ◽
Vol 36
◽
pp. S94-S95
◽
1989 ◽
Vol 103
(8)
◽
pp. 743-746
◽
2017 ◽
Vol 83
(9)
◽
pp. 1912-1920
◽
Keyword(s):
2007 ◽
Vol 36
(1)
◽
pp. 26-31
◽